Back
Altisource Portfolio Solutions SA Vs. Ultragenyx Pharmaceutical, Inc. Industry Stock Comparison
Sell
6
ASPS
Altisource Portfolio Solutions SA
Last Price:
$6.62
Seasonality Move:
-5.17%
Sell
48
RARE
Ultragenyx Pharmaceutical, Inc.
Last Price:
$34.38
Seasonality Move:
6.21%
Sell
6
Altisource Portfolio Solutions SA (ASPS)
is a Sell
Is Altisource Portfolio Solutions SA a Buy, Sell or Hold?
-
The current Altisource Portfolio Solutions SA [ASPS] share price is $6.27. The Score for ASPS is 6, which is 88% below its historic median score of 50, and infers higher risk than normal.
-
ASPS is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
48
Ultragenyx Pharmaceutical, Inc. (RARE)
is a Sell
Is Ultragenyx Pharmaceutical, Inc. a Buy, Sell or Hold?
-
The current Ultragenyx Pharmaceutical, Inc. [RARE] share price is $36.23. The Score for RARE is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ASPS Stock Price Chart
What is Altisource Portfolio Solutions SA's stock price today?
-
The Altisource Portfolio Solutions SA share price today is $6.27Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ASPS is experiencing selling pressure, which indicates risk of future bearish movement.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical, Inc.'s stock price today?
-
The Ultragenyx Pharmaceutical, Inc. share price today is $36.23The current trend is moderately bearish and RARE is experiencing slight selling pressure.
ASPS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.89 | Sell |
| Relative Strength Index (14 RSI): | 24.4 | Sell |
| Chaikin Money Flow: | -10114 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.57 - 9.79) | Sell |
| Bollinger Bands (100): | (9.04 - 12.04) | Sell |
RARE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.97 | Buy |
| Relative Strength Index (14 RSI): | 61.17 | Buy |
| Chaikin Money Flow: | -296399 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (32.5 - 35.92) | Buy |
| Bollinger Bands (100): | (28.85 - 34.05) | Buy |
ASPS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.39 | Sell |
| 20-day SMA: | 8.44 | Sell |
| 50-day SMA: | 9.92 | Sell |
| 200-day SMA: | 9.23 | Sell |
| 8-day EMA: | 7.18 | Sell |
| 20-day EMA: | 8.15 | Sell |
| 50-day EMA: | 9.31 | Sell |
| 200-day EMA: | 9.85 | Sell |
RARE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.29 | Sell |
| 20-day SMA: | 34.52 | Buy |
| 50-day SMA: | 33.51 | Buy |
| 200-day SMA: | 33.72 | Buy |
| 8-day EMA: | 35.95 | Buy |
| 20-day EMA: | 34.99 | Buy |
| 50-day EMA: | 33.64 | Buy |
| 200-day EMA: | 34.82 | Buy |
Altisource Portfolio Solutions SA Earnings Growth & ASPS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and a decrease next year of $0.00 per share.
Ultragenyx Pharmaceutical, Inc. Earnings Growth & RARE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.39 per share, and an increase next year of $1.31 per share.
Altisource Portfolio Solutions SA Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ultragenyx Pharmaceutical, Inc. Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||